Journal article
Lipid-lowering treatment for secondary prevention of peripheral arterial occlusive disease Influence of the new guidelines of the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS)
Gefässchirurgie, v 25(3), pp 160-165
01 May 2020
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
In addition to arterial hypertension, smoking and diabetes mellitus, dyslipidemia is one of the primary risk factors that significantly influence the development and progress of peripheral arterial occlusive disease (PAOD). The treatment of dyslipidemia is of crucial importance, especially for lowering of low-density lipoprotein cholesterol (LDL-C) levels, which has been accentuated once again in the current guidelines of the European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS).
Metrics
Details
- Title
- Lipid-lowering treatment for secondary prevention of peripheral arterial occlusive disease Influence of the new guidelines of the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS)
- Creators
- J. F. Dopheide - University Hospital of BernH. Drexel - Vorarlberg Institute for Vascular Investigation and Treatment
- Publication Details
- Gefässchirurgie, v 25(3), pp 160-165
- Publisher
- Springer Nature
- Number of pages
- 6
- Resource Type
- Journal article
- Language
- German
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:000520802100002
- Scopus ID
- 2-s2.0-85082815538
- Other Identifier
- 991021860778304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Peripheral Vascular Disease